Search hospitals > Ontario > OTTAWA
Novartis Investigative Site
Claim this profileOTTAWA, Ontario K1H 8L6
Global Leader in Multiple Sclerosis
Global Leader in Sclerosis
Conducts research for Breast Cancer
Conducts research for Cancer
Conducts research for Chronic Urticaria
82 reported clinical trials
0 medical researchers
Summary
Novartis Investigative Site is a medical facility located in OTTAWA, Ontario. This center is recognized for care of Multiple Sclerosis, Sclerosis, Breast Cancer, Cancer, Chronic Urticaria and other specialties. Novartis Investigative Site is involved with conducting 82 clinical trials across 89 conditions. There are 0 research doctors associated with this hospital, such as .Top PIs
Clinical Trials running at Novartis Investigative Site
Multiple Sclerosis
Coronary Heart Disease
Sclerosis
Diffuse Large B-Cell Lymphoma
Breast Cancer
Coronary Artery Disease
Myocardial Ischemia
Lymphoblastic Leukemia-Lymphoma
B-Cell Lymphoma
Lymphoid Leukemia
Remibrutinib vs Teriflunomide
for Multiple Sclerosis
This trial compares two medications, remibrutinib and teriflunomide, for treating patients with relapsing multiple sclerosis. These patients have repeated episodes of symptoms and need effective treatments. The medications work by controlling the immune system to prevent it from causing damage to the nervous system. Teriflunomide is an approved medication for adults with relapsing multiple sclerosis.
Recruiting2 awards Phase 3
Fingolimod
for Pediatric Multiple Sclerosis
To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS)
Recruiting1 award Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Novartis Investigative Site?
Novartis Investigative Site is a medical facility located in OTTAWA, Ontario. This center is recognized for care of Multiple Sclerosis, Sclerosis, Breast Cancer, Cancer, Chronic Urticaria and other specialties. Novartis Investigative Site is involved with conducting 82 clinical trials across 89 conditions. There are 0 research doctors associated with this hospital, such as .